The Latest Breaking News from Eli Lilly

The pharmaceutical giant has already delivered massive gains this year, but Wall Street analysts have only gotten more bullish on the maker of Mounjaro and Zepbound.

Amazon, Taiwan Semiconductor and Eli Lilly are working toward buy points as funds load up.

As the earnings season nears its close, here are five ‘Strong Buy’-rated stocks that delivered exceptional earnings results.

Eli Lilly and Novo Nordisk kicked off the "vanity trade," but the trend could be extending to other industries as well.

Fund managers have been busy buying amid the ongoing market weakness. Four stocks are near buy points or are building bases.

Here's what may happen next for the pharma giant's stock price.

The market hasn't confirmed its rally attempt, but more leaders are stepping up. Check out these AI stocks not named Nvidia.

Here are the stocks making the biggest market moves today.

Monday's global sell-off turned into a stock market rally attempt. Palantir, Eli Lilly and Fortinet were among the earnings winners.

Eli Lilly has significantly outperformed the broader market over the past year, and Wall Street analysts are bullish about the stock’s prospects.

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +2.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.76%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.06%. US stocks on Thursday settled sharply higher. Stocks rallied Thursday after US weekly initial...